دورية أكاديمية
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
| العنوان: | NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. |
|---|---|
| المؤلفون: | Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA |
| المصدر: | Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2018 Dec; Vol. 16 (12), pp. 1429-1440. |
| نوع المنشور: | Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2010- : Cold Spring Harbor, N.Y. : Harborside Press Original Publication: Sudbury, MA : Jones and Bartlett Publishers, c2003- |
| مواضيع طبية MeSH: | Carcinoma/*therapy , Medical Oncology/*standards , Thyroid Neoplasms/*therapy, Antineoplastic Combined Chemotherapy Protocols/standards ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Carcinoma/diagnosis ; Carcinoma/mortality ; Carcinoma/pathology ; Clinical Trials as Topic ; Humans ; Image-Guided Biopsy/methods ; Image-Guided Biopsy/standards ; Neoplasm Staging ; Prognosis ; Protein Kinase Inhibitors/standards ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins B-raf/antagonists & inhibitors ; Proto-Oncogene Proteins B-raf/genetics ; Societies, Medical/standards ; Thyroid Gland/diagnostic imaging ; Thyroid Gland/pathology ; Thyroid Gland/surgery ; Thyroid Neoplasms/diagnosis ; Thyroid Neoplasms/genetics ; Thyroid Neoplasms/pathology ; Thyroidectomy/methods ; Thyroidectomy/standards ; Treatment Outcome ; United States |
| مستخلص: | The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights summarize the panel discussion behind recent updates to the guidelines, including the expanding role of molecular testing for differentiated thyroid carcinoma, implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and the addition of a new targeted therapy option for BRAF V600E-mutated anaplastic thyroid carcinoma. (Copyright © 2018 by the National Comprehensive Cancer Network.) |
| المشرفين على المادة: | 0 (Biomarkers, Tumor) 0 (Protein Kinase Inhibitors) EC 2.7.11.1 (BRAF protein, human) EC 2.7.11.1 (Proto-Oncogene Proteins B-raf) |
| تواريخ الأحداث: | Date Created: 20181215 Date Completed: 20191028 Latest Revision: 20191028 |
| رمز التحديث: | 20231215 |
| DOI: | 10.6004/jnccn.2018.0089 |
| PMID: | 30545990 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1540-1413 |
|---|---|
| DOI: | 10.6004/jnccn.2018.0089 |